Prevention of Opioid Overdose
UMass Chan Affiliations
Division of Medical Toxicology, Department of Emergency MedicineDocument Type
Journal ArticlePublication Date
2019-06-06Keywords
opioid use disorderopioids
opioid overdose
prevention
prescriber strategies
opioid therapy
Community Health and Preventive Medicine
Emergency Medicine
Health Services Administration
Health Services ResearchSubstance Abuse and Addiction
Metadata
Show full item recordAbstract
This review explains harm-reduction strategies for three groups of patients: those who have not received previous opioid therapy, those receiving long-term opioid therapy, and those with an opioid use disorder. It explains both risk assessment and the current approach to the use of medications for opioid use disorder.Source
Babu KM, Brent J, Juurlink DN. Prevention of Opioid Overdose. N Engl J Med. 2019 Jun 6;380(23):2246-2255. doi: 10.1056/NEJMra1807054. Link to article on publisher's site
DOI
10.1056/NEJMra1807054Permanent Link to this Item
http://hdl.handle.net/20.500.14038/28482PubMed ID
31167053Related Resources
Rights
Copyright © 2019 Massachusetts Medical Society. Publisher PDF posted after 6 months as allowed by the publisher's author rights policy at https://www.nejm.org/author-center/permissions.Scopus Count
Related items
Showing items related by title, author, creator and subject.
-
A Myth-Shattering Look at Addiction Prevention and Treatment, Based on ResearchDavid will share his research and personal experience about the importance of recognizing that addiction is a chronic brain disease that affects the whole family. “We know what to do when a person is sick with any other problem.” He will discuss how co-existing psychiatric disorders such as anxiety or depression can be underlying conditions and must be considered when deciding how to treat addiction. The stigma and shame attached to addiction is hindering our recovery from this public health issue. What can we learn from the past about other public health epidemics about getting rid of the stigma to make way for effective prevention and treatment? Learning Objectives: Learn about the brain science of addiction and how drug use before the brain is fully developed can affect the chances of drug addiction. • Learn that addiction is not a choice, it is a complex and chronic illness. • Understand that treatment is often more than a one-step process and effective treatment may need to include a dual diagnosis with a mental health condition. • Learn about effective strategies families can use to lessen the chances their children will become addicted. • Learn what we can do together legislatively to address prevention and access to treatment.
-
Oxybutynin treatment for buprenorphine-naloxone-induced hyperhidrosisHyperhidrosis occurs when sweating is excessive for thermoregulatory purposes, which may result in decreased quality of life and emotional stress for patients.Classified as primary and secondary, secondary hyperhidrosis is often related to an underlying cause. Certain medications have been reported to induce hyperhidrosis, including selective serotonin reuptake inhibitors, tricyclic antidepressants, and opioid agonists. We present the case of a woman with a history of opioid use disorder who experienced hyperhidrosis in the setting of partial opioid agonist and opioid antagonist therapy (buprenorphine-naloxone), who was treated successfully with oral oxybutynin 5 mg daily.
